ARCHIVES

Enzalutamide Reduced Risk of Progression By 81 Percent in Metastatic Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 37 No. 6 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

FDA Proposes To Require Electronic Submission

May 3, 2002

Cancer Control Dilemma: What To do With Successful Demonstrations

September 10, 1976

Budget Would Support 1,211 More Grants

February 7, 2003

Fisher Committee Suggest Program, NCI Changes To Enhance Surgical Oncology

April 1, 1977

Morale, Money Woes Hit MD Anderson

January 18, 2013

NCI Cooperative Group, Cancer Center Trials Listed

October 31, 2008